The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ollert, M. W.
Right arrow Articles by Vogel, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ollert, M. W.
Right arrow Articles by Vogel, C. W.

The Journal of Immunology, Vol 144, Issue 10 3862-3867, Copyright © 1990 by American Association of Immunologists


ARTICLES

C3-cleaving membrane proteinase. A new complement regulatory protein of human melanoma cells

MW Ollert, R Frade, A Fiandino, M Panneerselvam, EC Petrella, M Barel, MK Pangburn, R Bredehorst and CW Vogel
Department of Biochemistry, Georgetown University School of Medicine, Washington, DC 20007.

Human melanoma cells resistant to killing by the R24 mAb and human complement rapidly degrade surface-deposited C3b (M. Panneerselvam, S. Welt, L. J. Old, C.-W. Vogel. 1986. J. Immunol. 136:2534). We report that C-resistant melanoma cells express a membrane proteinase that can cleave C3b, generating a cleavage product with a molecular mass of approximately 30 kDa. The C3-cleaving proteinase was identified on the melanoma cells by its cross-reaction with antiserum to p57, a C3- cleaving proteinase previously isolated from human E membranes (C. Charriaut-Marlangue, M. Barel, R. Frade. 1986. Biochem. Biophys. Res. Commun. 140:1113). Preincubation of the C-resistant melanoma cells with anti-p57 IgG or their F(ab')2 fragments increased their susceptibility to complement killing from 25% to approximately 50% and reduced the rate of C3b cleavage and the amount of the 30-kDa fragment generated on the cells. Anti-p57 IgG stained C-resistant melanoma cells by indirect immunofluorescence and precipitated a protein with an apparent molecular mass of 65 kDa. This membrane protein, termed p65, was not detectable on C-susceptible melanoma cells. Membrane extracts from C- resistant melanoma cells also showed C3-cleaving activity when incubated with purified C3 or C3b, similarly generating a C3 fragment of approximately 35 kDa. This fluid-phase C3 cleaving activity could be partially inhibited by anti-p57 IgG. These data suggest that p65 is a C3-cleaving proteinase, antigenically related to p57, that is expressed on C-resistant melanoma cells and responsible for the C resistance of these cells. We propose that the membrane-bound C3-cleaving proteinase represents another C regulatory protein protecting host cells against killing by C.


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Y. Park, Y. P. Shin, C. H. Kim, H. J. Park, Y. S. Seong, B. S. Kim, S. J. Seo, and I. H. Lee
Immune Evasion of Enterococcus faecalis by an Extracellular Gelatinase That Cleaves C3 and iC3b
J. Immunol., November 1, 2008; 181(9): 6328 - 6336.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Crescenzo-Chaigne and S. van der Werf
Rescue of Influenza C Virus from Recombinant DNA
J. Virol., October 15, 2007; 81(20): 11282 - 11289.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Johswich, M. Martin, J. Thalmann, C. Rheinheimer, P. N. Monk, and A. Klos
Ligand Specificity of the Anaphylatoxin C5L2 Receptor and Its Regulation on Myeloid and Epithelial Cell Lines
J. Biol. Chem., December 22, 2006; 281(51): 39088 - 39095.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. David, M. W. Ollert, C. Vollmert, S. Heiligtag, B. Eickhoff, R. Erttmann, R. Bredehorst, and C.-W. Vogel
Human Natural Immunoglobulin M Antibodies Induce Apoptosis of Human Neuroblastoma Cells by Binding to a Mr 260,000 Antigen
Cancer Res., August 1, 1999; 59(15): 3768 - 3775.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.